As the Executive Vice President of Global R&D and Chief Medical Officer at Teva Pharmaceuticals, Eric Hughes leverages his extensive background as a physician-scientist to drive innovation and excellence in drug development. With a specialization in infectious diseases and immunology, Eric brings nearly two decades...
As the Executive Vice President of Global R&D and Chief Medical Officer at Teva Pharmaceuticals, Eric Hughes leverages his extensive background as a physician-scientist to drive innovation and excellence in drug development. With a specialization in infectious diseases and immunology, Eric brings nearly two decades of comprehensive experience across all phases of clinical development, from early-stage drug discovery to late-stage clinical trials. His leadership spans a diverse R&D organization of approximately 4,200 professionals, dedicated to the advancement of generic, biosimilar, and innovative medicines, particularly in the fields of neuroscience, immunology, and immuno-oncology.
Under Eric's guidance, Teva's R&D initiatives have a profound impact, reaching approximately 200 million patients globally each day. He is instrumental in fostering a culture of collaboration and scientific rigor, ensuring that the development pipeline is robust and responsive to patient needs. His expertise in clinical trials and biomarker identification enhances the precision of drug development, allowing for more targeted therapies that improve patient outcomes. Additionally, Eric's strategic oversight of clinical research organizations (CROs) facilitates efficient and effective study designs, optimizing the proof of concept for new therapies.
Eric's commitment to advancing medicine is evident in his focus on innovative approaches to treat complex diseases, particularly in the realm of infectious diseases and chronic conditions like hepatitis C (HCV). His vision for the future of R&D at Teva emphasizes not only the importance of scientific discovery but also the necessity of translating these discoveries into tangible benefits for patients worldwide. Through his leadership, Teva continues to be at the forefront of pharmaceutical innovation, making significant strides in improving global health.
